SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 62 filers reported holding SURFACE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $66,225 | +39794.6% | 95,083 | -52.9% | 0.00% | – |
| Q4 2022 | $166 | -99.9% | 202,064 | 0.0% | 0.00% | – |
| Q3 2022 | $210,000 | -79.7% | 202,064 | -68.0% | 0.00% | – |
| Q2 2022 | $1,034,000 | -52.7% | 630,478 | -15.1% | 0.00% | -100.0% |
| Q1 2022 | $2,184,000 | +12.8% | 742,962 | +83.5% | 0.00% | 0.0% |
| Q4 2021 | $1,936,000 | -3.7% | 404,977 | +52.4% | 0.00% | 0.0% |
| Q3 2021 | $2,011,000 | -57.0% | 265,667 | -57.6% | 0.00% | 0.0% |
| Q2 2021 | $4,674,000 | +19.6% | 626,516 | +24.9% | 0.00% | 0.0% |
| Q1 2021 | $3,907,000 | +149.8% | 501,514 | +196.6% | 0.00% | 0.0% |
| Q4 2020 | $1,564,000 | +170.6% | 169,104 | +101.5% | 0.00% | – |
| Q3 2020 | $578,000 | +259.0% | 83,914 | +241.9% | 0.00% | – |
| Q2 2020 | $161,000 | +250.0% | 24,544 | 0.0% | 0.00% | – |
| Q1 2020 | $46,000 | +9.5% | 24,544 | +66.5% | 0.00% | – |
| Q2 2019 | $42,000 | -60.0% | 14,739 | -33.2% | 0.00% | – |
| Q1 2019 | $105,000 | – | 22,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $2,061,817 | 9.68% |
| DAFNA Capital Management LLC | 1,100,000 | $768,680 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 1,300,000 | $908,440 | 0.14% |
| EcoR1 Capital, LLC | 3,082,959 | $2,154,372 | 0.07% |
| ARK Investment Management | 5,496,146 | $3,840,707 | 0.03% |
| Forefront Analytics, LLC | 61,156 | $42,737 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 230,292 | $161 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 113,219 | $79,117 | 0.01% |
| Knights of Columbus Asset Advisors LLC | 157,769 | $110,249 | 0.01% |
| Nikko Asset Management Americas, Inc. | 999,026 | $649,367 | 0.01% |